Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|July 26, 2014
Constrained bithiazoles: small molecule correctors of defective ΔF508-CFTR protein traffickingKeith C Coffman, Huy H Nguyen, Puay-Wah Phuan, et al.
Hepatology (Baltimore, Md.)|January 19, 2017
The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitisZongwen Shuai, Jinjun Wang, Madhu Badamagunta, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Benzoflavone activators of the cystic fibrosis transmembrane conductance regulator: towards a pharmacophore model for the nucleotide-binding domainMark F Springsteel, Luis J V Galietta, Tonghui Ma, et al.
Journal of Autoimmunity|July 19, 2011
Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivityPhornnop Naiyanetr, Jeffrey D Butler, Liping Meng, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 6, 2016
Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipationOnur Cil, Puay-Wah Phuan, Jung-Ho Son, et al.
Gastroenterology|January 16, 2004
Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosisSylvaine F A Bruggraber, Patrick S C Leung, Katsushi Amano, et al.
Hepatology (Baltimore, Md.)|June 20, 2008
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular diseaseKanji Wakabayashi, Zhe-Xiong Lian, Patrick S C Leung, et al.
Hepatology (Baltimore, Md.)|November 28, 2012
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisRichy C Y Chen, Phornnop Naiyanetr, Shang-An Shu, et al.
Pageof 22